Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

August 1, 2022

5 Lung Cancer-Related Stories to Commemorate World Lung Cancer Day

Author(s):

Brielle Benyon

In honor of World Lung Cancer Day, CURE® compiled the five most-read lung cancer-related news items from 2022 that patients may have missed.

Today is World Lung Cancer Day, and while there are still advancements that need to be made, new treatments and cutting-edge research has improved the quality and quantity of life for patients with the disease.

In honor of World Lung Cancer Day, we took a look at some of the most-read lung cancer-related news items from 2022.

  • A Step Forward in Treating KRAS G12-Mutated Lung Cancer. The KRAS mutation was previously seen as “undruggable” for patients with lung cancer, but now there is a drug, Lumakras (sotorasib) that is approved by the Food and Drug Administration (FDA), while others continue to be investigated.
  • Patient Receives Treatment With Novel Drug in First-in-Human Trial Assessing its Safety and Efficacy in Lung Cancer. Earlier this year, a clinical trial kicked off examining BDTX-1535 in patients with non-small cell lung that harbors an EGFR mutation of intrinsic or acquired resistance and has failed standard treatment cancer as well as glioblastoma (a type of brain cancer). Study results for the novel drug, which inhibits the EGFR alterations that help cancer cells grow, are expected to be published in 2024.
  • A Paradigm Shift in Early-Stage Lung Cancer May Be Leading to More Cures. Immunotherapy has made landmark advancements in the treatment of non-small cell lung cancer in recent years. Now, researchers are testing these drugs earlier in the treatment plan — before disease spreads — which may lead to an immune response against cancer that is, “permanent, even when the drug is stopped,” according to an expert.
  • What Patients With Lung Cancer Don’t Know May Be Critically Important. Biomarker testing has become common practice in lung cancer, as gaining more information about the cancer’s molecular makeup can help guide treatment decisions. However, many patients with lung cancer reported that they did not have these test results shared with them and less than 25% reported receiving a printed copy of their results.
  • FDA Approves Opdivo-Chemotherapy Regimen for Pre-Surgical Treatment for Non-Small Cell Lung Cancer. In March, the FDA approved Opdivo (nivolumab) plus doublet chemotherapy for the pre-surgical treatment of patients with surgery-eligible non-small cell lung cancer, marking a “turning point in how we treat resectable (non-small cell lung cancer),” according to an expert.

To stay up to date in the latest lung cancer news, check out CURE®’s Lung Cancer Page. Or, sign up for CURE®’s emails and get the news right in your inbox.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
Image of two doctors and text.
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of doctor.
Image of Dr. Boffa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Image of Dr. Reznick
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Related Content
Advertisement
Datroway received accelerated FDA approval for adults with EGFR+ advanced NSCLC: © stock.adobe.com.
June 23rd 2025

FDA Approves Datroway for EGFR-Mutated Advanced Lung Cancer

Spencer Feldman
Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and platinum chemotherapy.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms potentially boosting immune responses.
June 19th 2025

Exploring Palliative and Curative Radiation for Lung Cancer

Dr. Jared Weiss
Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms potentially boosting immune responses.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of lung.
June 18th 2025

Recent SCLC Data May Impact How Patients Are Treated Day-to-Day

Ryan Scott
Various trials within the small cell lung cancer space were brought to light following recent data, impacting how patients will be treated in the future.
Image of hands.
June 18th 2025

The Person Behind Their Diagnosis: Understanding the Patient

Ryan Scott
Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person behind their cancer diagnosis.
Related Content
Advertisement
Datroway received accelerated FDA approval for adults with EGFR+ advanced NSCLC: © stock.adobe.com.
June 23rd 2025

FDA Approves Datroway for EGFR-Mutated Advanced Lung Cancer

Spencer Feldman
Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and platinum chemotherapy.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms potentially boosting immune responses.
June 19th 2025

Exploring Palliative and Curative Radiation for Lung Cancer

Dr. Jared Weiss
Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms potentially boosting immune responses.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of lung.
June 18th 2025

Recent SCLC Data May Impact How Patients Are Treated Day-to-Day

Ryan Scott
Various trials within the small cell lung cancer space were brought to light following recent data, impacting how patients will be treated in the future.
Image of hands.
June 18th 2025

The Person Behind Their Diagnosis: Understanding the Patient

Ryan Scott
Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person behind their cancer diagnosis.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.